Authors



Claudia Gabai, MPH

Latest:

Hypoglycemia Upon Hospital Admission From Long-term Care: Health Care Resource Use

This analysis of a hospital billing database describes inpatient length of stay, intensive care unit length of stay, comorbidities, and costs for patients with diabetes after admission with hypoglycemia from long-term care or home.


Amy Headings, PhD, RD

Latest:

Approaches for Overcoming Barriers to Cross-Sector Data Sharing

The authors identified challenges to cross-sector data sharing and the approaches used to overcome these challenges in the Mid-Ohio Farmacy, a partnership to address food insecurity.


Paul I. Musey Jr, MD, MSc

Latest:

Health-Related Social Needs, Methods, and Concerns for a Polysocial Risk Score: An Expert Panel

A polysocial risk score is a potentially useful addition to the growing methodologies to better understand and address health-related social needs.


Kara S. Aplin, MD

Latest:

Discharge Before Noon: Is the Sun Half Up or Half Down?

Discharge before noon was associated with longer length of stay in patients with medical diagnoses and shorter length of stay in surgical patients.


Abi Sriharan, DPhil, MSc (Oxon)

Latest:

Addressing Evolving Patient Concerns Around Telehealth in the COVID-19 Era

With a rapid shift to telehealth during the coronavirus disease 2019 (COVID-19) pandemic, clinicians, health care organizations, and policy makers must consider and address patients’ evolving needs, concerns, and expectations.


Sarah Gaillot, PhD

Latest:

Telephone Follow-Up on Medicare Patient Surveys Remains Critical

Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.



Suja Rajan, PhD

Latest:

Evaluation of a Collaborative Model Between Managed Care and Affordable Housing on Acute Care Costs

A collaborative service model between a managed care organization and an affordable housing provider reduced acute care use and costs.


Jingyan Yang, DrPH, MHS

Latest:

Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology Practice

Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.


Blythe J.S. Adamson, PhD

Latest:

ACA Medicaid Expansion Association With Racial Disparity Reductions in Timely Cancer Treatment

Medicaid expansion was associated with a reduction in the racial disparity in timely treatment of patients with advanced cancer in the United States.


Umur Hatipoğlu, MD

Latest:

Diabetes Associated With Higher Health Care Utilization and Poor Outcomes After COPD-Related Hospitalizations

Patients with diabetes and chronic obstructive pulmonary disease (COPD) have worse outcomes when hospitalized and appear to be more vulnerable to respiratory and nonrespiratory complications after a COPD exacerbation, which highlights the need for targeted interventions in this population.


John Mullahy, PhD

Latest:

Care Transition Management and Patient Outcomes in Hospitalized Medicare Beneficiaries

Hospital care transition activity facilitates uptake of Medicare-reimbursed transitional care management, which is associated with lower spending and better patient outcomes.


Sagar Lonial MD, FACP

Latest:

The Role of MRD Status in Post-ASCT Treatment Decisions and Clinical Integration

Panelists discuss how minimal residual disease (MRD) status can guide post-transplant treatment decisions, particularly for high-risk patients who don’t achieve MRD negativity and patients considering discontinuation of long-term maintenance therapy.


Ashwin Gupta, MD

Latest:

Diagnosis Patterns and Stress Testing Trends After Implementing High-Sensitivity Troponin Assay

This study found that switching from a conventional troponin assay to a high-sensitivity troponin assay resulted in changes to diagnosis patterns and stress testing trends.


Dr Jeffrey Rutledge | Image Credit: LinkedIn
Geoffrey Rutledge, MD, PhD

Latest:

Experts Push to Preserve Telehealth, Payment Parity Post Pandemic

Experts agree that the expansion of telehealth was one of the most significant positive outcomes of the COVID-19 pandemic.


Stephen R. Saklad, PharmD, BCPP

Latest:

Predicting Drug-Drug and Drug-Gene Interactions in a Community Pharmacy Population

The probability of drug interactions increases when genetic polymorphisms are considered, indicating that pharmacogenetic assessment may be useful in predicting the presence and severity of interactions.



Ruaa Mansi, MD, MPH

Latest:

Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?

Calculating a social score is feasible and it predicts cardiovascular outcomes. In order to do this, institutions have to collect social determinants of health.


Lisandro D. Colantonio, MD, PhD

Latest:

Diabetes, Gaps in Care Coordination, and Preventable Adverse Events

The authors examined the association of diabetes with self-reported gaps in care coordination and self-reported preventable adverse events using data from a national sample of older adults.


Matthew O. Hurford, MD

Latest:

Increased Likelihood of Psychiatric Readmission With Medicaid Expansion vs Legacy Coverage

Individuals who became eligible for Medicaid through Medicaid expansion have an increased likelihood of psychiatric readmission compared with their legacy-enrolled counterparts.


Douglas Barthold, PhD

Latest:

Utilization of Low- and High-Value Health Care by Individuals With and Without Cognitive Impairment

Low-value service utilization is common among all older adults, and utilization of some high-value services decreases after the onset of cognitive decline.


Sabarish Ayyappan, MD | image credit: cancercenter.com
Sabarish Ayyappan, MD

Latest:

Cost-Effectiveness Strategies Vital for Streamlining Care in Hematologic Malignancies

More cost-effectiveness studies evaluating bispecific antibody or chimeric antigen receptor T-cell therapies are necessary for enhancing care in myeloma and lymphoma.


Ayodeji Adegunsoye, MD, MSc, PhD, FACP, FCCP

Latest:

From ATS 2025: Analysis of Data Supporting PDE4 Inhibition in IPF

Panelists discuss recent phase 3 trial results of a novel oral agent for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), highlighting its ability to significantly reduce lung function decline and mortality—even when added to existing antifibrotic therapies—while maintaining a favorable safety and tolerability profile.


Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO

Latest:

Closing Thoughts on Iron Deficiency Anemia

Panelists discuss how the successful management of iron deficiency anemia requires a comprehensive approach combining early detection, appropriate choice of iron formulation, careful monitoring of treatment response, and addressing barriers to care while emphasizing the importance of patient education and health care system support in achieving optimal outcomes.


Neil A. Solomon, MD

Latest:

Refining Intensive Care Management Programs: Can Providing the Neediest Patients the Right Care in the Right Setting Improve Health and Reduce Expenditures?

Given the severe unmet needs of the most vulnerable members of our communities, geographic expansion and rigorous evaluations of comparable, highly personalized care management interventions are warranted.


Catherine Lee, PhD

Latest:

Challenges of Fracture Risk Assessment in Asian and Black Women

Differences in bone density and FRAX fracture risk scores among Black and Asian women yield greater discordance in fracture risk estimation compared with White women.


Caroline A. Presley, MD, MPH

Latest:

Measuring Continuity of Care for Diabetes: Which Visits to Include?

This study examined how inclusion of different provider specialties affected Continuity of Care Index values, year-to-year stability, and association with emergency department visits.


Bryan C. Hambley, MD, MPH

Latest:

Payment Incentives and the Use of Higher-Cost Drugs: A Retrospective Cohort Analysis of Intravenous Iron in the Medicare Population

During a period of rapid fluctuation in the intravenous iron market, there was increased use of a more expensive drug that afforded providers additional revenue.


Mark Tesell, PharmD, BCPS

Latest:

Evaluating Proactive Outreach for Prior Authorization Recertifications in Medicaid Patients

Implementing a proactive provider outreach program resulted in significantly more prior authorization recertifications and a reduction in time to submission.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo